Evidence map›Paper›PMID 32829582›Full record

ArticleAnnals of laboratory medicine2021

Reference Intervals for Thyroid-Associated Hormones and the Prevalence of Thyroid Diseases in the Chinese Population.

Yutong Zou, Danchen Wang, Xinqi Cheng, Chaochao Ma, Songbai Lin, Yingying Hu, Songlin Yu, Liangyu Xia, Honglei Li, Yicong Yin and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of laboratory medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 2 countries.

Yutong ZouDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0001-5750-5286
Danchen WangDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0003-2688-3203
Xinqi ChengDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0001-8228-5078
Chaochao MaDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0003-4870-2231
Songbai LinDepartment of Health Care, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0003-1433-9825
Yingying HuDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0001-7791-6058
Songlin YuDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0002-5284-9730
Liangyu XiaDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0002-9900-4479
Honglei LiDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0003-3839-1564
Yicong YinDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0002-8879-943X
Huaicheng LiuDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0001-6366-7396
Dianxi ZhangDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0002-3541-6255
Kui ZhangDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0002-8370-8412
Xiaolan LianDepartment of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0002-9877-3858
Tengda XuDepartment of Health Care, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0003-1774-3786
Ling QiuDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & China Academy of Medical Science, Beijing, China.ORCID 0000-0002-0734-8144
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThyroid diseases are highly prevalent worldwide, but their diagnosis remains a challenge. We established reference intervals (RIs) for thyroid-associated hormones and evaluated the prevalence of thyroid diseases in China.

methodsAfter excluding outliers based on the results of ultrasound screening, thyroid antibody tests, and the Tukey method, the medical records of 20,303 euthyroid adults, who visited the Department of Health Care at Peking Union Medical College Hospital from January 2014 to December 2018, were analyzed. Thyroid-associated hormones were measured by the Siemens Advia Centaur XP analyzer. The RIs for thyroid-associated hormones were calculated according to the CLSI C28-A3 guidelines, and were compared with the RIs provided by Siemens. The prevalence of thyroid diseases over the five years was evaluated and compared using the chi-square test.

resultsThe RIs for thyroid stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), total thyroxine (TT4), and total triiodothyronine (TT3) were 0.71-4.92 mIU/L, 12.2-20.1 pmol/L, 3.9-6.0 pmol/L, 65.6-135.1 nmol/L, and 1.2-2.2 nmol/L, respectively. The RIs of all hormones except TT4 differed significantly between males and females. The RIs of TSH increased with increasing age. The prevalence of overt hypothyroidism, overt hyperthyroidism, subclinical hypothyroidism, and subclinical hyperthyroidism was 0.5% and 0.8%, 0.2% and 0.6%, 3.8% and 6.1%, and 3.3% and 4.7% in males and females, respectively, which differed from those provided by Siemens.

conclusionsSex-specific RIs were established for thyroid-associated hormones, and the prevalence of thyroid diseases was determined in the Chinese population.

Indexed as

AdultChinaCross-Sectional StudiesFemaleHumansHyperthyroidismHypothyroidismImmunoassayMaleMiddle AgedPrevalenceReference ValuesRegression AnalysisSex FactorsThyroid HormonesThyroxineThyroid HormonesThyroxineTriiodothyronineHyperthyroidismhypothyroidismPrevalenceReference intervalThyroid-associated hormones

Identifiers

PMID32829582
PMCPMC7443523
OpenAlexW3080602395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.